SCHEMBL10041230

SCHEMBL10041230

C=Cc1ccc(Cl)c(C(=O)N(C)OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
SLC6A3 Q01959 1/20 0.41
TRPA1 O75762 1/20 0.37
CXCL12 P48061 3/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PKM P14618 1/20 0.35
RAB9A P51151 1/20 0.35
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
CLK1 P49759 1/20 0.33
DYRK1A Q13627 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
NR1I3 Q14994 1/20 0.33
LMNA P02545 1/20 0.33
MLYCD O95822 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8574359 0.80 ALDH1A1 (0.52) ALDH1A1SLC6A3CXCL12PKMRAB9A
SCHEMBL305871 0.78 SLC6A3 (0.48) ALDH1A1SLC6A3MEN1KMT2APKM
SCHEMBL29641926 0.78 MEN1 (0.49) ALDH1A1TRPA1MEN1KMT2ATP53
SCHEMBL17461032 0.77 ALDH1A1 (0.45) ALDH1A1SLC6A3MEN1KMT2APKM
SCHEMBL307646 0.77 ALDH1A1 (0.45) ALDH1A1SLC6A3MEN1KMT2APKM
SCHEMBL25298572 0.77 ALDH1A1 (0.45) ALDH1A1SLC6A3MEN1KMT2APKM
SCHEMBL153277 0.77 ALDH1A1 (0.71) ALDH1A1SLC6A3MEN1KMT2APKM
SCHEMBL10041228 0.74 ALDH1A1 (0.57) ALDH1A1MEN1KMT2APKMRAB9A
SCHEMBL10040966 0.74 HPGD (0.39) ALDH1A1TRPA1MEN1KMT2ARAB9A
SCHEMBL308205 0.73 POLB (0.59) ALDH1A1KMT2ATP53HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019496-A1 C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION RPOCESS AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 WO disclosed